CovidShiny: An Integrated Web Tool for SARS-CoV-2 Mutation Profiling and Molecular Diagnosis Assay Evaluation In Silico.

The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continuing to evolve and accumulate mutations. While various bioinformatics tools have been developed for SARS-CoV-2, a well-curated mutation-tracking database integrated with in silico evaluation for molecular diagnostic assays is currently unavailable. To address this, we introduce CovidShiny, a web tool that integrates mutation profiling, in silico evaluation, and data download capabilities for genomic sequence-based SARS-CoV-2 assays and data download. It offers a feasible framework for surveilling the mutation of SARS-CoV-2 and evaluating the coverage of the molecular diagnostic assay for SARS-CoV-2. With CovidShiny, we examined the dynamic mutation pattern of SARS-CoV-2 and evaluated the coverage of commonly used assays on a large scale. Based on our in silico analysis, we stress the importance of using multiple target molecular diagnostic assays for SARS-CoV-2 to avoid potential false-negative results caused by viral mutations. Overall, CovidShiny is a valuable tool for SARS-CoV-2 mutation surveillance and in silico assay design and evaluation.

One-Pot Bioconversion of Lignin-Derived Substrates into Gallic Acid.

Lignin is regarded as the most abundant renewable aromatic compound on earth. In this study, we established Escherichia coli-based whole-cell biocatalytic systems to efficiently convert two lignin-derived substrates (ferulic acid and p-coumaric acid) to gallic acid. For the synthesis of gallic acid from ferulic acid, we used the recombinant E. coli expressing feruloyl-CoA synthetase and enoyl-CoA hydratase/aldolase from Pseudomonas putida, aldehyde dehydrogenase (HFD1) from Saccharomyces cerevisiae, vanillic acid O-demethylase (VanAB) from P. putida, and a mutant version of p-hydroxybenzoate hydroxylase (PobAY385F) from P. putida. Under the fed-batch mode, 19.57 mM gallic acid was obtained from 20 mM ferulic acid with a conversion rate of 97.9%. To achieve gallic acid synthesis from p-coumaric acid, we replaced VanAB with the two-component flavin-dependent monooxygenase (HpaBC) from E. coli. Under optimal conditions, 20 mM p-coumaric acid afforded the production of 19.96 mM gallic acid with near 100% conversion. To the best of our knowledge, our work represented the first study to develop E. coli-based whole-cell biocatalysts for the eco-friendly synthesis of gallic acid from lignin-derived renewable feedstocks.

Engineering an Optogenetic CRISPRi Platform for Improved Chemical Production.

Microbial synthesis of chemicals typically requires the redistribution of metabolic flux toward the synthesis of targeted products. Dynamic control is emerging as an effective approach for solving the hurdles mentioned above. As light could control the cell behavior in a spatial and temporal manner, the optogenetic-CRISPR interference (opto-CRISPRi) technique that allocates the metabolic resources according to different optical signal frequencies will enable bacteria to be controlled between the growth phase and the production stage. In this study, we applied a blue light-sensitive protein EL222 to regulate the expression of the dCpf1-mediated CRISPRi system that turns off the competitive pathways and redirects the metabolic flux toward the heterologous muconic acid synthesis in Escherichia coli. We found that the opto-CRISPRi system dynamically regulating the suppression of the central metabolism and competitive pathways could increase the muconic acid production by 130%. These results demonstrated that the opto-CRISPRi platform is an effective method for enhancing chemical synthesis with broad utilities.